In principle, protection against development of overt gastric disease might stem from simple competition – whereby carriage of an avirulent (cagA-negative) strain diminishes the vigour of growth of a coexisting virulent strain, thereby reducing its impact on host tissues. The gene discussed is S100A8; the disease is stomach disorder.